Paralytic poliomyelitis--United States, 1980-1994
- PMID: 9048844
Paralytic poliomyelitis--United States, 1980-1994
Abstract
The Advisory Committee on Immunization Practices (ACIP) recently recommended a sequential vaccination schedule of two doses of inactivated poliovirus vaccine (IPV) followed by two doses of oral poliovirus vaccine (OPV) for routine vaccination of children in the United States (1). ACIP revised its recommendation for routine poliovirus vaccination for three reasons: 1) paralytic poliomyelitis attributable to indigenously acquired wild poliovirus has not occurred in the United States since 1979 (2), 2) progress toward global eradication of poliomyelitis has reduced the risk for importation of wild poliovirus into the United States (3), and 3) vaccine-associated paralytic poliomyelitis (VAPP) continues to occur. ACIP has recommended that implementation of this new vaccination schedule begin in early 1997. This report summarizes both the epidemiology of paralytic poliomyelitis in the United States reported during 1980-1994 and provisional reports for 1995-1996 and updates the estimated risk for VAPP. These findings indicate that the overall estimated risk for VAPP has remained constant.
Similar articles
-
Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 1997 Jan 24;46(RR-3):1-25. MMWR Recomm Rep. 1997. PMID: 9026708
-
Vaccine policy changes and epidemiology of poliomyelitis in the United States.JAMA. 2004 Oct 13;292(14):1696-701. doi: 10.1001/jama.292.14.1696. JAMA. 2004. PMID: 15479934
-
Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2000 May 9;49(RR-5):1-22; quiz CE1-7. MMWR Recomm Rep. 2000. PMID: 15580728
-
Ensuring preparedness for potential poliomyelitis outbreaks: Recommendations for the US poliovirus vaccine stockpile from the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP).Arch Pediatr Adolesc Med. 2004 Dec;158(12):1106-12. doi: 10.1001/archpedi.158.12.1106. Arch Pediatr Adolesc Med. 2004. PMID: 15583093 Review.
-
Poliovirus vaccine options.Am Fam Physician. 1999 Jan 1;59(1):113-8, 125-6. Am Fam Physician. 1999. PMID: 9917578 Review.
Cited by
-
Neurologic Safety Monitoring of COVID-19 Vaccines: Lessons From the Past to Inform the Present.Neurology. 2021 Oct 19;97(16):767-775. doi: 10.1212/WNL.0000000000012703. Epub 2021 Sep 2. Neurology. 2021. PMID: 34475124 Free PMC article. Review.
-
MicroRNA-134 regulates poliovirus replication by IRES targeting.Sci Rep. 2017 Oct 4;7(1):12664. doi: 10.1038/s41598-017-12860-z. Sci Rep. 2017. PMID: 28978937 Free PMC article.
-
The final stages of the global eradication of poliomyelitis.Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24;368(1623):20120140. doi: 10.1098/rstb.2012.0140. Print 2013 Aug 5. Philos Trans R Soc Lond B Biol Sci. 2013. PMID: 23798688 Free PMC article. Review.
-
Sabin and wild type polioviruses from children who presented with acute flaccid paralysis in Nigeria.Afr Health Sci. 2012 Sep;12(3):345-54. doi: 10.4314/ahs.v12i3.16. Afr Health Sci. 2012. PMID: 23382751 Free PMC article.
-
The Spatial Dynamics of Poliomyelitis in the United States: From Epidemic Emergence to Vaccine-Induced Retreat, 1910-1971.Ann Assoc Am Geogr. 2005 Jun;95(2):269-293. doi: 10.1111/j.1467-8306.2005.00460.x. Ann Assoc Am Geogr. 2005. PMID: 16741562 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
